Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$0.54 and traded as low as C$0.30. Aptose Biosciences shares last traded at C$0.31, with a volume of 5,500 shares changing hands.
Aptose Biosciences Price Performance
The company has a debt-to-equity ratio of 670.80, a quick ratio of 5.41 and a current ratio of 0.80. The company’s 50 day moving average price is C$0.34 and its 200 day moving average price is C$0.54. The company has a market cap of C$5.52 million, a price-to-earnings ratio of -0.05 and a beta of 1.36.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
See Also
- Five stocks we like better than Aptose Biosciences
- High Flyers: 3 Natural Gas Stocks for March 2022
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- About the Markup Calculator
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- What is the Hang Seng index?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
